First-Episode Schizophrenia: A Focus on Pharmacological Treatment and Safety Considerations

Author： Kelly Deanna L.   Conley Robert R.   Carpenter William T.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.65, Iss.8, 2005-01, pp. : 1113-1138

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacological Management of First-Episode Schizophrenia and Related Nonaffective Psychoses

By Bradford D.W.   Perkins D.O.   Lieberman J.A.  

Drugs, Vol. 63, Iss. 21, 2003-01 ,pp. : 2265-2283

Adis International

Access to resources Recommend Favorite

Rate and predictors of non‐response to first‐line antipsychotic treatment in first‐episode schizophrenia

By  

Human Psychopharmacology: Clinical And Experimental (Electronic), Vol. 30, Iss. 3, 2015-05 ,pp. : 173-182

John Wiley & Sons Inc

Access to resources Recommend Favorite

Antipsychotic Drugs for First-Episode Schizophrenia: A Comparative Review

By Salimi Kayvon   Jarskog L. Fredrik   Lieberman Jeffrey A.  

CNS Drugs, Vol. 23, Iss. 10, 2009-10 ,pp. : 837-855

Adis International

Access to resources Recommend Favorite

Variants of dopamine and serotonin candidate genes as predictors of response to risperidone treatment in first-episode schizophrenia

By Ikeda Masashi   Yamanouchi Yoshio   Kinoshita Yoko   Kitajima Tsuyoshi   Yoshimura Reiji   Hashimoto Shuji   O’’Donovan Michael C   Nakamura Jun   Ozaki Norio   Iwata Nakao  

Pharmacogenomics, Vol. 9, Iss. 10, 2008-10 ,pp. : 1437-1443

Future Medicine

Access to resources Recommend Favorite

Risperidone Long-Acting Injection in the Treatment of First Episode Schizophrenia

By Rocca P.   Sandei L.   M. Bava I.   Frieri T.  

Current Psychopharmacology, Vol. 2, Iss. 1, 2013-02 ,pp. : 29-36

Bentham Science Publishers

Access to resources Recommend Favorite